PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.40%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
5.54%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
-2.20%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-2.95%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
1.99%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
1.65%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.67%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.22%
Share count expansion well above ADI's 0.07%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.22%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.05%
Dividend reduction while ADI stands at 6.98%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
54.47%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
319.48%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
36.34%
10Y revenue/share CAGR under 50% of ADI's 96.42%. Michael Burry would suspect a lasting competitive disadvantage.
7.05%
5Y revenue/share CAGR 1.25-1.5x ADI's 5.26%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-15.54%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
138.05%
10Y OCF/share CAGR 1.25-1.5x ADI's 114.10%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
-10.13%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-25.04%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
93.78%
Net income/share CAGR above 1.5x ADI's 1.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-11.27%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-40.93%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
93.15%
Below 50% of ADI's 351.59%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
108.41%
5Y equity/share CAGR at 75-90% of ADI's 123.39%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
56.21%
Below 50% of ADI's 115.34%. Michael Burry suspects a serious short-term disadvantage in building book value.
330.83%
10Y dividend/share CAGR above 1.5x ADI's 148.91%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
68.63%
Similar 5Y dividend/share CAGR to ADI's 70.17%. Walter Schloss sees parallel philosophies in mid-term capital returns.
27.31%
3Y dividend/share CAGR at 75-90% of ADI's 33.28%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
2.39%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.56%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
0.47%
Asset growth well under 50% of ADI's 0.97%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.14%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-2.10%
We’re deleveraging while ADI stands at 15.28%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
4.18%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.20%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.